Review of Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical Trial

Pre-publication Review of

Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical Trial

Reviewed On June 19, 2023

Verified

Submitted to

Reviewed by

Actions

Reviewed on June 19, 2023

Source

References

G., T. A., K., R. K., Vicki, H., A., M. E., B., B. P., R., K. L., D., W. B., G., S. H., Hyunsuk, S. 2023. Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical Trial. Cancers.